Global Vascular Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $6.93M

  • Investors
  • 13

Global Vascular General Information

Description

Developer of a drug-eluting stent delivery system designed for the treatment of lower limb artery disease. The company's nanotechnology suppresses thrombus adhesion and allows cell integration with the stent without inhibiting it, helping medical staff to undergo stent treatment on the patients while being gentle on the body

Contact Information

Website
www.g-vasc.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Mirio Jimbocho 11 Floor
  • 1-28-1 Kanda Jimbocho, Chiyoda-ku
  • Tokyo
  • Japan
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Mirio Jimbocho 11 Floor
  • 1-28-1 Kanda Jimbocho, Chiyoda-ku
  • Tokyo
  • Japan

Global Vascular Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Global Vascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series B) 24-Jun-2025 $6.93M Completed Generating Revenue
4. Early Stage VC (Series A) 05-Dec-2023 Completed Generating Revenue
3. Seed Round 10-May-2023 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 01-Jan-2022 Completed Startup
To view Global Vascular’s complete valuation and funding history, request access »

Global Vascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class B Preferred
Class A Preferred
Ordinary Shares 857,143 $2.02 $2.02 1x $2.02 5.19%
To view Global Vascular’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Global Vascular Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medikit (Diagnostic Equipment) Corporation Minority
Mitsui Sumitomo Kaijo Capital Corporate Venture Capital Minority
Sumitomo Mitsui Trust Bank Investment Bank Minority
Tokyo University of Science Innovation Capital Corporation Minority
Fast Track Initiative Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Global Vascular FAQs

  • When was Global Vascular founded?

    Global Vascular was founded in 2022.

  • Where is Global Vascular headquartered?

    Global Vascular is headquartered in Tokyo, Japan.

  • What industry is Global Vascular in?

    Global Vascular’s primary industry is Drug Delivery.

  • Is Global Vascular a private or public company?

    Global Vascular is a Private company.

  • What is the current valuation of Global Vascular?

    The current valuation of Global Vascular is .

  • What is Global Vascular’s current revenue?

    The current revenue for Global Vascular is .

  • How much funding has Global Vascular raised over time?

    Global Vascular has raised $18.8M.

  • Who are Global Vascular’s investors?

    Medikit (Diagnostic Equipment), Mitsui Sumitomo Kaijo Capital, Sumitomo Mitsui Trust Bank, Tokyo University of Science Innovation Capital, and Fast Track Initiative are 5 of 13 investors who have invested in Global Vascular.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process